SCHEMBL7890248

SCHEMBL7890248

C[C@H]1CN(C(=O)Nc2ccccc2)CCN1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.66
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
TP53 P04637 3/20 0.56
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 1/20 0.55
TSHR P16473 2/20 0.53
KDM4E B2RXH2 2/20 0.52
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
ALDH1A1 P00352 2/20 0.51
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
HRH4 Q9H3N8 1/20 0.49
MAPT P10636 1/20 0.49
ALOX15 P16050 1/20 0.49
GRIN2B Q13224 1/20 0.49
RBP4 P02753 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16178505 0.87 RAB9A (0.57) POLBNPC1RAB9ASMN1; SMN2TP53
SCHEMBL23951569 0.87 POLB (0.55) POLBNPC1RAB9ASMN1; SMN2TP53
SCHEMBL16178748 0.83 POLB (0.46) POLBNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL16178759 0.83 NPC1 (0.60) POLBNPC1RAB9ASMN1; SMN2TP53
SCHEMBL6716470 0.83 MAPT (0.65) NPC1RAB9ASMN1; SMN2CYP1A2CYP2D6
SCHEMBL30965841 0.83 CNR2 (0.53) HPGDGRIN2B
SCHEMBL16178483 0.82 HTT (0.65) POLBNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL5193941 0.82 POLB (0.57) POLBNPC1RAB9ASMN1; SMN2TP53
SCHEMBL16178734 0.81 GAA (0.60) POLBRAB9ASMN1; SMN2ALDH1A1HTT
SCHEMBL656655 0.81 POLB (0.97) POLBNPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010102663-A1 PIPERAZINE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2010-09-16 WO disclosed